Quantcast

Latest Combination drugs Stories

2015-05-26 12:28:04

CHESTNUT RIDGE, N.Y., May 26, 2015 /PRNewswire/ -- Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., today announced the launch of Cortisporin(®)-TC Otic Suspension

2015-05-19 08:40:08

-- New rewards-based program demonstrates Galderma's commitment to aesthetics market with industry-leading benefits for healthcare providers and consumers -- FORT WORTH, Texas, May

2015-05-08 08:27:37

- Contrave® net sales total $11.5 million in the first full quarter of launch SAN DIEGO, May 8, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.

2015-04-28 12:31:46

VP/GM of New Aesthetic & Corrective Business Unit; Senior Director of Organizational Health FORT WORTH, Texas, April 28, 2015 /PRNewswire/ -- Galderma, the company dedicated to skin

2015-04-15 12:30:22

NEW YORK, April 15, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased Orexigen Therapeutics, Inc.

2015-03-30 08:31:51

SAN DIEGO, March 30, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Tom Cannell has joined as Chief Commercial Officer.

2015-03-24 20:24:21

LONDON, March 24, 2015 /PRNewswire/ -- Key Findings--Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth

2015-03-06 12:26:11

NEW YORK, March 6, 2015 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Orexigen


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'